374Water Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
SCWO$2.32-2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED CHANGES IN STOCKHOLDERS’ EQUITY
| Preferred Stock · Common Stock · Additional · Other · Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of Shares · Amount · Number of shares · Amount · paid-in capital · Accumulated Deficit · Comprehensive Income · Stockholders' Equity | |||||||||
| Balances, December 31, 2023 | - | $ | - | 13,266,711 | $1,327 | $30,696,882 | $(15,953,504) | $2,471 | $14,747,176 |
| Issuance of shares of common stock for services - employees and directors | - | - | 30,121 | 3 | 383,876 | - | - | 383,879 | |
| Accretion of stock-based compensation - options | - | - | - | - | 907,225 | - | - | 907,225 | |
| Accretion of stock-based compensation - restricted stock | - | - | - | - | 308,399 | - | - | 308,399 | |
| Stock options issued for legal settlement | - | - | - | - | 112,697 | - | - | 112,697 | |
| Stock option exercises - cashless and cash | - | - | 149,965 | 15 | 59,985 | - | - | 60,000 | |
| Issuance of shares of common stock for cash in ATM , net of issuance costs | - | - | 5,051 | 1 | (3,094) | - | - | (3,093) | |
| Issuance of shares of common stock for cash in offering , net of issuance costs | - | - | 978,350 | 98 | 11,392,514 | - | - | 11,392,612 | |
| Net loss | - | - | - | - | - | (12,434,114) | - | (12,434,114) | |
| Balances, December 31, 2024 | - | - | 14,430,198 | 1,444 | 43,858,484 | (28,387,618) | 2,471 | 15,474,781 | |
| Issuance of shares of common stock for services | - | - | 82,958 | 8 | 290,864 | - | - | 290,872 | |
| Accretion of stock-based compensation - options | - | - | - | - | 1,834,648 | - | - | 1,834,648 | |
| Accretion of stock-based compensation - restricted stock | - | - | - | - | 1,711,998 | 1,711,998 | |||
| Issuance of restricted common stock to executives | - | - | 198,154 | 20 | (20) | - | - | - | |
| Stock option exercises - cashless and cash | - | - | 131,176 | 13 | 23,987 | - | - | 24,000 | |
| Issuance of shares of common stock for cash in ATM, net of issuance costs | - | - | 2,279,180 | 228 | 8,908,412 | - | - | 8,908,640 | |
| Issuance of shares of common stock for payment of accrued expense | - | - | 22,105 | 2 | 104,998 | - | - | 105,000 | |
| Deemed dividend from warrant modification | - | - | - | - | 573,928 | (573,928) | - | - | |
| Warrant repurchase | - | - | - | - | (649,980) | - | - | (649,980) | |
| Net loss | - | - | - | - | - | (20,975,052) | - | (20,975,052) | |
| Balances, December 31, 2025 | - | $ | - | 17,143,771 | $1,715 | $56,657,319 | $(49,936,598) | $2,471 | $6,724,907 |
The accompanying notes are an integral part of these consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.